Semaglutide medications like Ozempic and Wegovy reduce body weight by an average of 15 percent over 68 weeks when combined with lifestyle changes. The drugs work by acting on the brain to increase feelings of fullness and decrease appetite. However, they do not work equally for all people.

A multidisciplinary research team at the University of Alberta is investigating why some individuals respond better to semaglutide than others. The team, which includes Giovanna Guimaraes Lopes Bergamasco, Andrea M. Haqq, Carla Prado, and Rachel J. Skow, is exploring potential factors such as genetics, metabolism, body composition, lifestyle, microbiota, associated diseases, age, and sex.

The researchers are examining energy metabolism as a possible key to understanding variable responses to the medication. Energy metabolism measures total calories consumed versus total calories burned through vital processes like breathing, physical activity, and digestion. When people lose weight, their bodies naturally require less energy. Sometimes the body enters "energy-saving mode," burning fewer calories than expected. This metabolic adaptation, also called adaptive thermogenesis, can create weight-loss plateaus.

A recent review of studies investigating GLP-1 therapies on energy utilization found only a few studies exploring how semaglutide affects resting energy use, with findings that were neutral or inconclusive. The question remains open for exploration.

The University of Alberta team has access to a whole-room indirect calorimeter, a rare facility that can precisely measure each component of energy use. The researchers are currently recruiting participants with blood sugar regulation issues who are starting semaglutide treatment. They will follow their progress over six months to investigate changes in body weight, composition, and energy utilization.

Understanding how semaglutide influences energy use and body composition could help anticipate non-responders and enable more personalized approaches to obesity and Type 2 diabetes management.